Global Plasma Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview

• 1.1 Plasma Therapeutics Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Human Serum Protein
  • 1.2.2 Plasma-Derived Clotting Factor
  • 1.2.3 Immunoglobulins
  • 1.2.4 High Immunoglobulins
• 1.3 Market Analysis by Applications
  • 1.3.1 Research Laboratories And Institutions
  • 1.3.2 Hospitals
  • 1.3.3 Stand-Alone Blood Banks
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
    • 1.4.1.1 United States Market States and Outlook (2013-2023)
    • 1.4.1.2 Canada Market States and Outlook (2013-2023)
    • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2013-2023)
    • 1.4.2.2 France Market States and Outlook (2013-2023)
    • 1.4.2.3 UK Market States and Outlook (2013-2023)
    • 1.4.2.4 Russia Market States and Outlook (2013-2023)
    • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2013-2023)
    • 1.4.3.2 Japan Market States and Outlook (2013-2023)
    • 1.4.3.3 Korea Market States and Outlook (2013-2023)
    • 1.4.3.4 India Market States and Outlook (2013-2023)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
    • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
    • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 Baxter
  • 2.1.1 Business Overview
  • 2.1.2 Plasma Therapeutics Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Baxter Plasma Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.2 CSL Behring
  • 2.2.1 Business Overview
  • 2.2.2 Plasma Therapeutics Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 CSL Behring Plasma Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.3 Grifols Therapeutics
  • 2.3.1 Business Overview
  • 2.3.2 Plasma Therapeutics Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Grifols Therapeutics Plasma Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.4 Octapharma
  • 2.4.1 Business Overview
  • 2.4.2 Plasma Therapeutics Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Octapharma Plasma Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.5 Abeona Therapeutics
  • 2.5.1 Business Overview
  • 2.5.2 Plasma Therapeutics Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Abeona Therapeutics Plasma Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.6 ADMA Biologics
  • 2.6.1 Business Overview
  • 2.6.2 Plasma Therapeutics Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 ADMA Biologics Plasma Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.7 Amag Pharmaceuticals
  • 2.7.1 Business Overview
  • 2.7.2 Plasma Therapeutics Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Amag Pharmaceuticals Plasma Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.8 Antares Pharma
  • 2.8.1 Business Overview
  • 2.8.2 Plasma Therapeutics Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Antares Pharma Plasma Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.9 BioDelivery Sciences
  • 2.9.1 Business Overview
  • 2.9.2 Plasma Therapeutics Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 BioDelivery Sciences Plasma Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.10 Bio Products Laboratory
  • 2.10.1 Business Overview
  • 2.10.2 Plasma Therapeutics Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Bio Products Laboratory Plasma Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.11 Biota Pharmaceuticals
  • 2.11.1 Business Overview
  • 2.11.2 Plasma Therapeutics Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Biota Pharmaceuticals Plasma Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.12 Biotest Pharmaceuticals
  • 2.12.1 Business Overview
  • 2.12.2 Plasma Therapeutics Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Biotest Pharmaceuticals Plasma Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.13 China Biologic Products
  • 2.13.1 Business Overview
  • 2.13.2 Plasma Therapeutics Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 China Biologic Products Plasma Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Plasma Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

• 3.1 Global Plasma Therapeutics Sales and Market Share by Manufacturer (2016-2017)
• 3.2 Global Plasma Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
• 3.3 Market Concentration Rate
  • 3.3.1 Top 3 Plasma Therapeutics Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Plasma Therapeutics Manufacturer Market Share in 2017
• 3.4 Market Competition Trend

4 Global Plasma Therapeutics Market Analysis by Regions

• 4.1 Global Plasma Therapeutics Sales, Revenue and Market Share by Regions
  • 4.1.1 Global Plasma Therapeutics Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Plasma Therapeutics Revenue and Market Share by Regions (2013-2018)
• 4.2 North America Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 4.3 Europe Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 4.4 Asia-Pacific Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 4.5 South America Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 4.6 Middle East and Africa Plasma Therapeutics Sales and Growth Rate (2013-2018)

5 North America Plasma Therapeutics by Countries

• 5.1 North America Plasma Therapeutics Sales, Revenue and Market Share by Countries
  • 5.1.1 North America Plasma Therapeutics Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Plasma Therapeutics Revenue and Market Share by Countries (2013-2018)
• 5.2 United States Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 5.3 Canada Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 5.4 Mexico Plasma Therapeutics Sales and Growth Rate (2013-2018)

6 Europe Plasma Therapeutics by Countries

• 6.1 Europe Plasma Therapeutics Sales, Revenue and Market Share by Countries
  • 6.1.1 Europe Plasma Therapeutics Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Plasma Therapeutics Revenue and Market Share by Countries (2013-2018)
• 6.2 Germany Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 6.3 UK Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 6.4 France Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 6.5 Russia Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 6.6 Italy Plasma Therapeutics Sales and Growth Rate (2013-2018)

7 Asia-Pacific Plasma Therapeutics by Countries

• 7.1 Asia-Pacific Plasma Therapeutics Sales, Revenue and Market Share by Countries
  • 7.1.1 Asia-Pacific Plasma Therapeutics Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Plasma Therapeutics Revenue and Market Share by Countries (2013-2018)
• 7.2 China Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 7.3 Japan Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 7.4 Korea Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 7.5 India Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 7.6 Southeast Asia Plasma Therapeutics Sales and Growth Rate (2013-2018)

8 South America Plasma Therapeutics by Countries

• 8.1 South America Plasma Therapeutics Sales, Revenue and Market Share by Countries
  • 8.1.1 South America Plasma Therapeutics Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Plasma Therapeutics Revenue and Market Share by Countries (2013-2018)
• 8.2 Brazil Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 8.3 Argentina Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 8.4 Colombia Plasma Therapeutics Sales and Growth Rate (2013-2018)

9 Middle East and Africa Plasma Therapeutics by Countries

• 9.1 Middle East and Africa Plasma Therapeutics Sales, Revenue and Market Share by Countries
  • 9.1.1 Middle East and Africa Plasma Therapeutics Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Plasma Therapeutics Revenue and Market Share by Countries (2013-2018)
• 9.2 Saudi Arabia Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 9.3 UAE Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 9.4 Egypt Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 9.5 Nigeria Plasma Therapeutics Sales and Growth Rate (2013-2018)
• 9.6 South Africa Plasma Therapeutics Sales and Growth Rate (2013-2018)

10 Global Plasma Therapeutics Market Segment by Type

• 10.1 Global Plasma Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
  • 10.1.1 Global Plasma Therapeutics Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Plasma Therapeutics Revenue and Market Share by Type (2013-2018)
• 10.2 Human Serum Protein Sales Growth and Price
  • 10.2.1 Global Human Serum Protein Sales Growth (2013-2018)
  • 10.2.2 Global Human Serum Protein Price (2013-2018)
• 10.3 Plasma-Derived Clotting Factor Sales Growth and Price
  • 10.3.1 Global Plasma-Derived Clotting Factor Sales Growth (2013-2018)
  • 10.3.2 Global Plasma-Derived Clotting Factor Price (2013-2018)
• 10.4 Immunoglobulins Sales Growth and Price
  • 10.4.1 Global Immunoglobulins Sales Growth (2013-2018)
  • 10.4.2 Global Immunoglobulins Price (2013-2018)
• 10.5 High Immunoglobulins Sales Growth and Price
  • 10.5.1 Global High Immunoglobulins Sales Growth (2013-2018)
  • 10.5.2 Global High Immunoglobulins Price (2013-2018)

11 Global Plasma Therapeutics Market Segment by Application

• 11.1 Global Plasma Therapeutics Sales Market Share by Application (2013-2018)
• 11.2 Research Laboratories And Institutions Sales Growth (2013-2018)
• 11.3 Hospitals Sales Growth (2013-2018)
• 11.4 Stand-Alone Blood Banks Sales Growth (2013-2018)

12 Plasma Therapeutics Market Forecast (2018-2023)

• 12.1 Global Plasma Therapeutics Sales, Revenue and Growth Rate (2018-2023)
• 12.2 Plasma Therapeutics Market Forecast by Regions (2018-2023)
  • 12.2.1 North America Plasma Therapeutics Market Forecast (2018-2023)
  • 12.2.2 Europe Plasma Therapeutics Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Plasma Therapeutics Market Forecast (2018-2023)
  • 12.2.4 South America Plasma Therapeutics Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Plasma Therapeutics Market Forecast (2018-2023)
• 12.3 Plasma Therapeutics Market Forecast by Type (2018-2023)
  • 12.3.1 Global Plasma Therapeutics Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Plasma Therapeutics Market Share Forecast by Type (2018-2023)
• 12.4 Plasma Therapeutics Market Forecast by Application (2018-2023)
  • 12.4.1 Global Plasma Therapeutics Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Plasma Therapeutics Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

• 13.1 Sales Channel
  • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
• 13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

• 15.1 Methodology